Guido Oelkers
Directeur Général chez SWEDISH ORPHAN BIOVITRUM AB
Fortune : 11 M $ au 31/05/2024
Profil
Guido Oelkers is currently the Chief Executive Officer & Director at BSN medical International Holding GmbH & Co. KG and the Chief Executive Officer at BSN medical BV.
He is also the President & Chief Executive Officer at Swedish Orphan Biovitrum AB.
He serves as the Chairman at Nanolive SA and Director at Dova Pharmaceuticals, Inc. and Swedish Orphan Biovitrum, Inc. In the past, he served as the President & Chief Executive Officer at Gambro AB and Gambro Lundia AB.
He was also the Group Chief Executive Officer at BSN medical GmbH and Chief Executive Officer at Invida Group Pte Ltd.
He has also held positions at Takeda Pharmaceuticals International AG, Sartorius AG, Aventis Pharma Deutschland GmbH, Takeda A, and Nycomed AB.
He holds a doctorate from the University of South Australia and a graduate degree from London South Bank University.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
30/05/2024 | 427 107 ( 0,12% ) | 11 M $ | 31/05/2024 |
Postes actifs de Guido Oelkers
Sociétés | Poste | Début |
---|---|---|
SWEDISH ORPHAN BIOVITRUM AB | Directeur Général | 22/05/2017 |
DOVA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 12/11/2019 |
BSN medical BV
BSN medical BV Medical SpecialtiesHealth Technology BSN medical BV manufactures and distributes medical supplies. It offers Phlebology and compression therapy, plaster, taping and bandaging, wound care fixation, and infection prevention. The company was founded in April 2001 and is headquartered in Almere, the Netherlands. | Directeur Général | - |
Swedish Orphan Biovitrum, Inc.
Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Swedish Orphan Biovitrum, Inc. operates as an international rare disease company providing access to treatments that make a significant difference for people with rare diseases. Its business areas include haemophilia, immunology and specialty care. The company is headquartered in Waltham, MA. | Directeur/Membre du Conseil | - |
BSN medical International Holding GmbH & Co. KG
BSN medical International Holding GmbH & Co. KG Medical SpecialtiesHealth Technology BSN medical International Holding GmbH & Co. KG manufactures and develops medical supplies and equipment. It specializes in the development and manufacture of the acute wound care, compression therapy, orthopedics, fracture management, physiotherapy and bandage segments. The firm products include wound dressings, medical skin care items, compression bandages, supports braces, synthetic castings, plasters and medical accessories. The company is headquartered in Hamburg, Germany. | Directeur Général | - |
Nanolive SA
Nanolive SA Medical SpecialtiesHealth Technology Nanolive SA develops revolutionary tomographic microscope to look instantly inside living cells in 3D. Its device scans cell division, cell organelles and cell morphology, cell differentiation, cell-cell interaction, intracellular trafficking, cellular remodeling processes, drug monitoring, and in vitro fertilization. The company was founded in November 2013 by Yann Cotte, Sebastien Equis, and Andreas Kern, Fatih Toy, Christian Depeursinge and is headquartered in Ecublens, Switzerland. | Président | - |
Anciens postes connus de Guido Oelkers
Sociétés | Poste | Fin |
---|---|---|
BSN Medical Holding
BSN Medical Holding Financial ConglomeratesFinance BSN Medical Holding provides investment services. The private company is based in Luxemburg, Luxembourg. | Directeur Général | 01/01/2017 |
Gambro AB
Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Directeur Général | 01/01/2013 |
Aventis Pharma Deutschland GmbH
Aventis Pharma Deutschland GmbH Pharmaceuticals: MajorHealth Technology Aventis Pharma Deutschland GmbH produces pharmaceutical products. It offers prescription drugs, human vaccines, and therapeutic proteins businesses. Aventis Pharma Deutschland plans and designs plants and process control systems in the areas of active ingredients production and finished drugs. The company is headquartered in Frankfurt am Main, Germany. | Corporate Officer/Principal | - |
░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
Formation de Guido Oelkers
University of South Australia | Doctorate Degree |
London South Bank University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
SARTORIUS AG | Health Technology |
Entreprise privées | 15 |
---|---|
Invida Group Pte Ltd.
Invida Group Pte Ltd. Pharmaceuticals: MajorHealth Technology Invida Group Pte Ltd. Was manufactured and distributed pharmaceutical products. The company was founded in 2005 and is headquartered in Singapore. | Health Technology |
Takeda Pharmaceuticals International AG
Takeda Pharmaceuticals International AG Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland. | Health Technology |
Aventis Pharma Deutschland GmbH
Aventis Pharma Deutschland GmbH Pharmaceuticals: MajorHealth Technology Aventis Pharma Deutschland GmbH produces pharmaceutical products. It offers prescription drugs, human vaccines, and therapeutic proteins businesses. Aventis Pharma Deutschland plans and designs plants and process control systems in the areas of active ingredients production and finished drugs. The company is headquartered in Frankfurt am Main, Germany. | Health Technology |
Gambro AB
Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Health Technology |
Gambro Lundia AB
Gambro Lundia AB Medical DistributorsDistribution Services Gambro Lundia AB operates as a medical technology company. It develops, manufactures, and distributes products and treatments for kidney and liver dialysis, treatment of myeloma kidney, and other extracorporeal treatments for chronically and acutely ill patients. The firm also holds shares in other companies. The company was founded on February 18, 1953 and is headquartered in Lund, Sweden. | Distribution Services |
BSN medical GmbH
BSN medical GmbH Pharmaceuticals: MajorHealth Technology BSN medical GmbH develops and markets wound care and related vascular diseases, lymphology and non-invasive orthopedic products. The firm specializes in the supply and manufacture of medical accessories for wound care, compression therapy, orthopedics, fracture management, physiotherapy and bandage applications. It markets products under brands, such as Leukoplast, Leukomed, Gypsona, Orthoglass, JOBSt, Radiante, Delta-cast, Actimove and Tridocur. Its focus areas encompass product innovation, brand development and hands-on training and workshops. The company was founded in April 2001 and is headquartered in Hamburg, Germany. | Health Technology |
Meda AB
Meda AB Pharmaceuticals: MajorHealth Technology Meda AB engages in the research, development, manufacture, and sale of pharmaceutical and medical products. It offers respiratory, dermatology, pain and inflammation, consumer healthcare, and over-the-counter products. The company was founded by Gert Lennart Perlhagen in 1999 and is headquartered in Solna, Sweden. | Health Technology |
BSN medical International Holding GmbH & Co. KG
BSN medical International Holding GmbH & Co. KG Medical SpecialtiesHealth Technology BSN medical International Holding GmbH & Co. KG manufactures and develops medical supplies and equipment. It specializes in the development and manufacture of the acute wound care, compression therapy, orthopedics, fracture management, physiotherapy and bandage segments. The firm products include wound dressings, medical skin care items, compression bandages, supports braces, synthetic castings, plasters and medical accessories. The company is headquartered in Hamburg, Germany. | Health Technology |
Takeda A/S
Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Finance |
BSN medical BV
BSN medical BV Medical SpecialtiesHealth Technology BSN medical BV manufactures and distributes medical supplies. It offers Phlebology and compression therapy, plaster, taping and bandaging, wound care fixation, and infection prevention. The company was founded in April 2001 and is headquartered in Almere, the Netherlands. | Health Technology |
BSN Medical Holding
BSN Medical Holding Financial ConglomeratesFinance BSN Medical Holding provides investment services. The private company is based in Luxemburg, Luxembourg. | Finance |
Swedish Orphan Biovitrum, Inc.
Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Swedish Orphan Biovitrum, Inc. operates as an international rare disease company providing access to treatments that make a significant difference for people with rare diseases. Its business areas include haemophilia, immunology and specialty care. The company is headquartered in Waltham, MA. | Health Technology |
Dova Pharmaceuticals, Inc.
Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist. The company was founded on March 24, 2016 and is headquartered in Durham, NC. | Health Technology |
Nycomed AB
Nycomed AB Pharmaceuticals: MajorHealth Technology Nycomed AB With a broad portfolio of products and a powerful pipeline, they work in a wide range of therapeutic areas, particularly cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. Nycomed engaged in all aspects of a product's life, from research and development to customer relations. They also work closely with innovative research-based companies, constantly looking for products with real promise for patients. They believe that everything do matters to someone. So they work carefully to make sure they get what they do right. They focus on results and respond quickly to the needs of patients and healthcare providers, giving them the best possible experience from working with clients. By doing this, they can achieve vision of being the preferred pharmaceutical company. | Health Technology |
Nanolive SA
Nanolive SA Medical SpecialtiesHealth Technology Nanolive SA develops revolutionary tomographic microscope to look instantly inside living cells in 3D. Its device scans cell division, cell organelles and cell morphology, cell differentiation, cell-cell interaction, intracellular trafficking, cellular remodeling processes, drug monitoring, and in vitro fertilization. The company was founded in November 2013 by Yann Cotte, Sebastien Equis, and Andreas Kern, Fatih Toy, Christian Depeursinge and is headquartered in Ecublens, Switzerland. | Health Technology |